A multicenter, first-in-pediatrics phase I study of ridaforolimus (AP23573, MK-8669) in patients (pts) with refractory solid tumors.
Year: 2010
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: L. Gore, T. M. Trippett, H. M. Katzenstein, J. L. Boklan, A. Narendaren, A. Smith, M. Macy, N. Narasimhan, C. D. Turner, M. L. Nieder
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2249838928